Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial
Wang, Michael L, Prof, Lee, Hun, MD, Chuang, Hubert, MD, Wagner-Bartak, Nicolaus, MD, Hagemeister, Frederick, Prof, Westin, Jason, MD, Fayad, Luis, MD, Samaniego, Felipe, MD, Turturro, Francesco, Prof, Oki, Yasuhiro, MD, Chen, Wendy, PA, Badillo, Maria, MSN, Nomie, Krystle, PhD, Rosa, Maria DeLa, BS, Zhao, Donglu, MD, Lam, Laura, PhD, Addison, Alicia, MS, Zhang, Hui, BSN, Young, Ken H, MD, Li, Shaoying, MD, Santos, David, MD, Medeiros, L Jeffrey, Prof, Champlin, Richard, Prof, Romaguera, Jorge, Prof, Zhang, Leo, MD
Published in The lancet oncology (01.01.2016)
Published in The lancet oncology (01.01.2016)
Get full text
Journal Article